Skip to content

Ansa Bio Appoints Dr. Matthew McManus as Chair of the Board

  • Published
  • Ansa Biotechnologies, a pioneer of next-generation DNA synthesis, today announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors.
  • Dr. McManus brings decades of experience in the life sciences industry to the Board.

View the press release